ASX
Neuren Pharmaceuticals Limited
NEU:ASX•Healthcare
Sensitive ASX Announcement
Patent to 2034 granted in Europe for Neuren's NNZ-2591
Published: 03/12/19, 08:52am (AEST)•2 pages